CurrentRheuma coverage · page 10 of 11
Lupus Science & Medicine
Latest from Lupus Science & Medicine
Lupus Sci Med
Azathioprine metabolite levels and outcomes during pregnancies with rheumatic disease
Cohort studyLupus & APS
Lupus Sci Med
Risk factors of first thrombosis in obstetric antiphospholipid syndrome
Cohort studyLupus & APS
Lupus Sci Med
Clinical significance of exostosin 1 in confirmed and suspected lupus membranous nephropathy
Cohort studyLupus & APS
Lupus Sci Med
Lupus Sci Med
Lupus Sci Med
Lupus Sci Med
Development and psychometric evaluation of a physician global assessment for type 2 systemic lupus erythematosus symptoms
Guideline or statementLupus & APS
Lupus Sci Med
Canadian patient experiences of lupus nephritis: a qualitative analysis
Research articleLupus & APS
Lupus Sci Med
Lupus Sci Med
Genotype-guided new approach for dose optimisation of hydroxychloroquine administration in Chinese patients with SLE
Cross-sectional studyLupus & APS
Lupus Sci Med
Lupus Sci Med
Lupus Sci Med
Lupus Sci Med
Lupus Sci Med
Lupus Sci Med
Mononuclear cells from patients with rhupus are influenced by TNF in their production of gp130/sIL-6Rb and APRIL
Mechanistic studyLupus & APS
Lupus Sci Med
Lupus Sci Med
Lupus Sci Med
Association of patient copayment and medication adherence in systemic lupus erythematosus
Cohort studyLupus & APS
Lupus Sci Med
Relationship between retinal microvascular impairment and subclinical atherosclerosis in SLE
Cross-sectional studyLupus & APS
Lupus Sci Med
Lupus Sci Med
B cell polygenic risk scores associate with anti-dsDNA antibodies and nephritis in systemic lupus erythematosus
Diagnostic or prognostic studyLupus & APS
Lupus Sci Med
Lupus Sci Med
Lupus Sci Med
Lupus Sci Med
Systemic Lupus Erythematosus Risk Probability Index: ready for routine use? Results from a Chinese cohort
Diagnostic or prognostic studyLupus & APS
Lupus Sci Med
Serum interferon-alpha predicts in-hospital mortality in patients hospitalised with acute severe lupus
Diagnostic or prognostic studyLupus & APS
Lupus Sci Med
Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase II trial
Secondary analysisLupus & APS
Lupus Sci Med
Lupus Sci Med
Lupus Sci Med
Abnormally high expression of D1-like dopamine receptors on lupus CD4+ T cells promotes Tfh cell differentiation
Mechanistic studyLupus & APS
Lupus Sci Med
Vitamin D level in patients with systemic lupus erythematosus: its relationship to disease course and bone mineral density
Cross-sectional studyLupus & APS
Lupus Sci Med
Lupus Sci Med
Lupus Sci Med
Lupus Sci Med
Lupus Sci Med
Lupus Sci Med
Lupus Sci Med
Lupus Sci Med